This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eth Zürich (Eidgenössische Technische Hochschule Zürich). Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Bartolomeo Angelici and Compact Genetic Logic Gates.
Introduction
Bartolomeo Angelici is an inventor associated with ETH Zurich (Eidgenössische Technische Hochschule Zürich) and based in Basel, Switzerland. His patent work concerns genetic logic gates designed to support precise cell targeting and potential disease treatment.
Latest Patents
Angelici is associated with 1 patent: “Method to Treat Disease Using a Nucleic Acid Vector Encoding a Highly Compact Multi-Input Logic Gate.” The patent describes contiguous DNA sequences that encode compact, multi-input genetic logic gates for precise in vivo cell targeting. It also outlines methods of treating disease by combining in vivo delivery with these DNA sequences.
Career Highlights
The available information connects Angelici’s work to genetic engineering and therapeutic applications. His patent focuses on using nucleic acid vectors and genetic logic to direct treatment toward selected cells in the body.
Collaborations
Angelici’s listed institutional affiliation is ETH Zurich. The provided information does not identify specific co-inventors or other collaborators.
Conclusion
Bartolomeo Angelici’s patent reflects research into compact genetic logic gates and their potential use in targeted disease treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile